Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
An adjuvanted, low-dose, pandemic influenza A (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults.
J Infect Dis. 2008 Sep 1;198(5):642-9. doi: 10.1086/590913.
J Infect Dis. 2008.
PMID: 18576945
Clinical Trial.
Immunogenicity and safety of three doses of a bivalent (B:4:p1.19,15 and B:4:p1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescents.
Boutriau D, Poolman J, Borrow R, Findlow J, Domingo JD, Puig-Barbera J, Baldó JM, Planelles V, Jubert A, Colomer J, Gil A, Levie K, Kervyn AD, Weynants V, Dominguez F, Barberá R, Sotolongo F.
Boutriau D, et al. Among authors: kervyn ad.
Clin Vaccine Immunol. 2007 Jan;14(1):65-73. doi: 10.1128/CVI.00230-06. Epub 2006 Oct 25.
Clin Vaccine Immunol. 2007.
PMID: 17065257
Free PMC article.
Clinical Trial.
Item in Clipboard
Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study.
Van Damme P, Moiseeva A, Marichev I, Kervyn AD, Booy R, Kuriyakose S, Brockway A, Ng SP, Leyssen M, Jacquet JM.
Van Damme P, et al. Among authors: kervyn ad.
BMC Infect Dis. 2010 Dec 20;10:357. doi: 10.1186/1471-2334-10-357.
BMC Infect Dis. 2010.
PMID: 21171982
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite